• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The SMALL Trial: A Big Change for Small Breast Cancers.

作者信息

Morgan J, Potter S, Sharma N, McIntosh S A, Coles C E, Dodwell D, Elder K, Gaunt C, Lyburn I D, McIntosh S A, Morgan J, Paramasivan S, Pinder S, Pirrie S, Potter S, Rea D, Roberts T, Sharma N, Stobart H, Taylor-Phillips S, Wallis M, Wilcox M

机构信息

University of Sheffield, FU32, The Medical School, Sheffield, UK.

Bristol Centre for Surgical Research, Population Health Sciences, Bristol Medical School, Bristol, UK; Bristol Breast Care Centre, Southmead Hospital, Bristol, UK.

出版信息

Clin Oncol (R Coll Radiol). 2019 Sep;31(9):659-663. doi: 10.1016/j.clon.2019.05.008. Epub 2019 May 31.

DOI:10.1016/j.clon.2019.05.008
PMID:31160130
Abstract
摘要

相似文献

1
The SMALL Trial: A Big Change for Small Breast Cancers.小型乳腺癌试验：小乳腺癌治疗的重大变革
Clin Oncol (R Coll Radiol). 2019 Sep;31(9):659-663. doi: 10.1016/j.clon.2019.05.008. Epub 2019 May 31.
2
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.来自BIG 1-98和SOFT临床试验的人表皮生长因子受体2低表达、激素受体阳性早期乳腺癌的基因组特征及预后意义
JCO Precis Oncol. 2025 Jan;9:e2400599. doi: 10.1200/PO-24-00599. Epub 2025 Jan 24.
3
Understanding the BIG results: Insights from the BIG 1-98 trial analyses.解读BIG研究结果：来自BIG 1-98试验分析的见解
Adv Ther. 2008 Dec;25(12):1257-75. doi: 10.1007/s12325-008-0128-5.
4
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.绝经后雌激素受体阳性乳腺癌患者雄激素受体表达的预后和预测价值：来自乳腺国际集团试验 1-98 的结果。
Breast Cancer Res. 2019 Feb 22;21(1):30. doi: 10.1186/s13058-019-1118-z.
5
The impact of personalized medicine on survival: comparisons of results in metastatic breast, colorectal and non-small-cell lung cancers.个体化医学对生存的影响：转移性乳腺癌、结直肠癌和非小细胞肺癌结果的比较。
Cancer Treat Rev. 2014 May;40(4):485-94. doi: 10.1016/j.ctrv.2013.09.012. Epub 2013 Sep 25.
6
SMALL: open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancer-protocol for a phase III randomised multicentre trial.小型乳腺癌：开放手术与微创真空辅助切除术治疗筛查发现的小型乳腺癌——一项III期随机多中心试验方案
BMJ Open. 2025 Apr 8;15(4):e099702. doi: 10.1136/bmjopen-2025-099702.
7
Female breast cancer incidence predisposing risk factors identification using nationwide big data: a matched nested case-control study in Taiwan.利用全国性大数据识别女性乳腺癌发病倾向风险因素：台湾一项匹配的巢式病例对照研究。
BMC Cancer. 2022 Aug 4;22(1):849. doi: 10.1186/s12885-022-09913-6.
8
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.来曲唑和他莫昔芬单独及序贯用于绝经后甾体激素受体阳性乳腺癌患者的评价：中位随访 8.1 年的 BIG 1-98 随机临床试验。
Lancet Oncol. 2011 Nov;12(12):1101-8. doi: 10.1016/S1470-2045(11)70270-4. Epub 2011 Oct 20.
9
The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.国际乳腺癌研究组1-98试验：对激素敏感型早期乳腺癌女性意义重大的结果。
Expert Rev Anticancer Ther. 2007 May;7(5):627-34. doi: 10.1586/14737140.7.5.627.
10
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98.在一项比较绝经后乳腺癌辅助来曲唑和他莫昔芬治疗的随机试验中，雌激素受体共激活因子 AIB1 的预后和预测重要性：BIG 1-98 丹麦队列。
Breast Cancer Res Treat. 2017 Nov;166(2):481-490. doi: 10.1007/s10549-017-4416-0. Epub 2017 Aug 1.

引用本文的文献

1
Mapping the current landscape of locoregional therapy de-escalation trials in early breast cancer: a systematic review.绘制早期乳腺癌局部区域治疗降阶梯试验的当前格局：一项系统评价
NPJ Breast Cancer. 2025 Mar 30;11(1):32. doi: 10.1038/s41523-025-00744-9.
2
Ultrasound-Guided Vacuum-Assisted Excision (VAE) in Breast Lesion Management: An Experimental Comparative Study of Two Different VAE Devices Across Various Aspiration Levels and Window Sizes.超声引导下真空辅助切除术（VAE）在乳腺病变管理中的应用：对两种不同VAE设备在不同抽吸水平和窗口大小下的实验性比较研究
Diagnostics (Basel). 2025 Jan 24;15(3):272. doi: 10.3390/diagnostics15030272.
3
Minimally invasive treatment of early, good prognosis breast cancer-is this feasible?
早期、预后良好的乳腺癌的微创治疗——这是否可行？
Br J Radiol. 2024 May 7;97(1157):886-893. doi: 10.1093/bjr/tqae028.
4
Potential role of vacuum-assisted procedures in resecting breast cancers and highlighting selection criteria to support future trials.真空辅助手术在乳腺癌切除中的潜在作用及突出支持未来试验的选择标准。
Front Oncol. 2023 Sep 21;13:1239574. doi: 10.3389/fonc.2023.1239574. eCollection 2023.
5
Vacuum-assisted excision of breast lesions in surgical de-escalation: where are we?手术降级中乳腺病变的真空辅助切除术：我们目前的进展如何？
Radiol Bras. 2023 May-Jun;56(3):150-156. doi: 10.1590/0100-3984.2022.0078-en.
6
Complete Surgical Excision Is Necessary following Vacuum-Assisted Biopsy for Breast Cancer.乳腺癌真空辅助活检后必须进行完整的外科切除。
Curr Oncol. 2022 Nov 30;29(12):9357-9364. doi: 10.3390/curroncol29120734.
7
Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind Alliance.确定乳腺癌手术研究重点：英国与詹姆斯林德联盟的优先事项设定伙伴关系。
Breast Cancer Res Treat. 2023 Jan;197(1):39-49. doi: 10.1007/s10549-022-06756-4. Epub 2022 Nov 1.